Shaping the Future of MS Treatment: The Role of Generics and Biosimilars with high cost drugs pharmacist Lucy Wessels

In this episode we delve into the evolving landscape of multiple sclerosis treatment, focusing on generics and biosimilars. It features a conversation with pharmacist Lucy Wessels, highlighting the safety, effectiveness, and cost benefits of generics and biosimilars in managing MS. The discussion emphasizes the importance of patient education, collaborative decision-making with healthcare providers, and dispelling misconceptions like the 'nocebo' effect around these treatment option. 00:00 Welcome and Introduction to the Episode01:06 Understanding Generics and Biosimilars in MS Treatment03:42 Diving Deeper: The Difference Between Generics and Biosimilars11:58 Addressing Concerns: Side Effects and Tolerability14:34 Enhancing Patient Understanding and Acceptance20:22 The Nocebo Effect and Its Impact on Treatment Perception24:34 Future of MS Treatment: Embracing Generics and Biosimilars31:52 Concluding Thoughts and Key TakeawaysBecome a supporter of this podcast: https://www.spreaker.com/podcast/beewellwithms-podcast-by-dr-agne-straukiene--5762905/support.